The prognostic value of P2RY13 at the protein level was explored with Clinical Proteomic Tumor Analysis Consortium (National Cancer Institute; https://proteomics.cancer.gov/programs/cptac), and the results revealed that a high P2RY13 protein level predicted improved prognosis (P = 0.021; Fig. S3B). This evidence concerns the gene P2RY13 and neoplasm.